People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Healthtech, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RefleXion Medical, Inc. | — | Healthtech | Series D+ | $413.0M | $1.3B | 2016 |
| Galvanize Therapeutics, Inc. | — | Biotechnology | Series C | $150.7M | $582.3M | 2025 |
| ShockWave Medical, Inc. | — | Healthtech | Series C | $144.8M | $255.8M | 2018 |
| Inspirna, Inc. | — | Biotechnology | Series C | $141.9M | $1.1B | 2016 |
| Coaxia Inc | — | Biotechnology | Series B | $40.0M | $893.0M | 2009 |
| Mainstay Medical, Inc. | — | Other Health Care | Seed | $3.7M | $12.4M | 2010 |
ANTOINE PAPIERNIK at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ANTOINE PAPIERNIK on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jay Watkins | 2 | 6 |
| Doug Godshall | 2 | 3 |
| Colin Cahill | 2 | 2 |
| Seth Harrison | 1 | 19 |
| Jack Nielsen | 1 | 13 |
| Nael Kassar | 1 | 11 |
| Frederic Moll | 1 | 10 |
| Denise Barbut | 1 | 9 |
| FRED MOLL | 1 | 8 |
| Frederic H. Moll | 1 | 8 |
| Greg Garfield | 1 | 8 |
| David Lewis | 1 | 7 |
| Brent Ahrens | 1 | 7 |
| Marc-Andre Marcotte | 1 | 6 |
| James Bullock | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Peter Shagory | 1 | 5 |
| B. KRISTINE JOHNSON | 1 | 5 |
| William Burkoth | 1 | 5 |
| David McIntyre | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.